Directed Reductive Amination of β-Hydroxy-ketones:  Convergent Assembly of the Ritonavir/Lopinavir Core

Dirk Menche,* Fatih Arikan, Jun Li, and Sven Rudolph
Gesellschaft fr Biotechnologische Forschung mbH (recently renamed to Helmholtz-Zentrum fr Infektionsforschung GmbH), Medizinische Chemie, Mascheroder Weg 1, D-38124 Braunschweig, Germany
Org. Lett., 2007, 9 (2), pp 267–270
DOI: 10.1021/ol062715y
Publication Date (Web): December 23, 2006
Copyright © 2007 American Chemical Society
*

In papers with more than one author, the asterisk indicates the name of the author to whom inquiries about the paper should be addressed.

, dirk.menche@helmholtz-hzi.de

Abstract

Abstract Image

An efficient procedure for the directed reductive amination of β-hydroxy-ketones (3) for the stereoselective preparation of 1,3-syn-amino alcohols (6) is reported. The operationally simple protocol uses Ti(iOPr)4 for coordination of the intermediate imino alcohol (5) and PMHS as the reducing agent. The method was expanded to an asymmetric aldol reductive amination sequence to allow a highly convergent synthesis of the hydroxy-amine core of the HIV-protease inhibitors ritonavir and lopinavir.

Tools

History

  • Published In Issue January 18, 2007
  • Received November 7, 2006

Recommend & Share

Related Content

Other ACS content by these authors: